prophylaxis [inpr]    
Hepatitis B Virus [virs]    
Recurrence [phpr]    
Liver Transplant [topp]    
Registries [inpr]    
studies [mnob]    
Aim [idcn]    
To [qlco]    
Evaluable [ftcn]    
Prophylactic [phsu]    
Efficacy [qlco]    
Combination [qlco]    
Different [qlco]    
Id [fish]    
Analogue [chvs]    
Method [inpr]    
% total [qnco]    
Positive [qnco]    
patient [podg]    
China [geoa]    
Liver Transplant [topp]    
Registries [inpr]    
Database [inpr]    
Low dose [qnco]    
INTRAMUSCULAR [ftcn]    
Combination [qlco]    
One [qnco]    
Id [fish]    
Analog [chvs]    
Show [inpr]    
To [qlco]    
Very [qlco]    
Cost Effectiveness [qnco]    
Recent [tmco]    
Report [inpr]    
Hepatitis B Virus [virs]    
Prophylactic [phsu]    
Outcome [ftcn]    
Compare [acty]    
base [ftcn]    
Prophylactic [phsu]    
Protocol [inpr]    
a group [clas]    
INTRAMUSCULAR [ftcn]    
Plus [qlco]    
Group [idcn]    
INTRAMUSCULAR [ftcn]    
Plus [qlco]    
Group N [inpr]    
INTRAMUSCULAR [ftcn]    
Plus [qlco]    
Compare [acty]    
Relate [orch]    
baseline [bodm]    
Characteristic [qlco]    
Three [qnco]    
Group [idcn]    
include [ftcn]    
Age [orga]    
Male [fndg]    
Sex [orgf]    
Score [qnco]    
Time [tmco]    
Transplant [topp]    
Child-Pugh Score [inpr]    
Time [tmco]    
Transplant [topp]    
HCC [neop]    
Pre [tmco]    
Transplant [topp]    
Hepatitis B e antigen [imft]    
Positive [qnco]    
Pre [tmco]    
Transplant [topp]    
Positive [qnco]    
Time [tmco]    
Transplant [topp]    
Pre-Therapy [tmco]    
Transplant [topp]    
Antiviral [phsu]    
Duration [tmco]    
Antiviral Therapy [topp]    
Transplant [topp]    
patient [podg]    
Calculate [ftcn]    
1+ [qnco]    
<3 [qnco]    
>5 [qnco]    
year [tmco]    
Survival Rate [qnco]    
Hepatitis B Virus [virs]    
Recurrence [phpr]    
Rate [acty]    
Different [qlco]    
Group [idcn]    
Potential [qlco]    
Risk factor [qnco]    
Analyzed [resa]    
Using [ftcn]    
Multivariate Analyses [qnco]    
Result [ftcn]    
Mean [qnco]    
Follow-up [fndg]    
Duration [tmco]    
MO [idcn]    
1+ [qnco]    
<3 [qnco]    
>5 [qnco]    
year [tmco]    
Survival Rate [qnco]    
Lower [spco]    
a group [clas]    
Group [idcn]    
c 2 [lipd]    
1+ [qnco]    
<3 [qnco]    
>5 [qnco]    
year [tmco]    
Hepatitis B Virus [virs]    
Recurrence [phpr]    
Rate [acty]    
High [qlco]    
a group [clas]    
Group [idcn]    
1-7 [gngm]    
0/5 [qnco]    
3 5 [qnco]    
1/5 [qnco]    
1/5 [qnco]    
Significance [qnco]    
*Difference [qnco]    
Exist [cnce]    
Group [idcn]    
Group [idcn]    
1+ [qnco]    
<3 [qnco]    
>5 [qnco]    
year [tmco]    
Hepatitis B Virus [virs]    
Recurrence [phpr]    
Rate [acty]    
Hepatocellular carcinoma [neop]    
High [qlco]    
Viral Load [fndg]    
Prophylactic [phsu]    
Protocol [inpr]    
Associated [qlco]    
Hepatitis B Virus [virs]    
Recurrence [phpr]    
Conclusion [idcn]    
Low dose [qnco]    
INTRAMUSCULAR [ftcn]    
Combination [qlco]    
Id [fish]    
Analog [chvs]    
provides [food]    
Effect [qlco]    
prophylaxis [inpr]    
Hepatitis B Virus [virs]    
Recurrence [phpr]    
Plus [qlco]    
